Oculogica Adds to IP Portfolio with Patent for Assessment of Impairment Due to Cannabis

by Sofia Fund | Jun 16, 2021 | Portfolio Company News

Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection

Click here to read the full press release.

Older post: Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent Partners

Newer post: Joylux announces new expanded products to support women through menopause